Product Name: Diclofenac Potassium Anti-Inflammatory GMP Pharmaceutical Technology: Chemical Synthesis Type: Biological Products State: Solid Usage Mode: Bulk Pharmaceuticals Application: Bulk Pharmaceuticals Validity: 12 Months Standard: Bp/USP Contain: 99% Packaging: 25kg/Drum Trademark: OEM Transport Package: 25kg/Drum Specification: Diclofenac Potassium Origin: China Product Description Product name: Diclofenac PotassiumTherapeutic: Anti-inflammatoryStandard: EP/USP/BP/JPRegulatory Status: GMP,DMF,CEPMolecular formula:C14H10Cl2KNO2Molecular weight: 334.24CAS:15307-81-0Contains(Diclofenac Potassium): ≥99%Packing:25kg/drumDiclofenac PotassiumName: Diclofenac PotassiumSynonym: DICLOFENAC POTASSIUM; DICLOFENAC POTASSIUM SALT; 2[(2, 6-dichlorophenyl)amino]benzeneacetic acid potassium salt; POTASSIUM [2-[(2, 6-DICHLOROPHENYL)AMINO]PHENYL]ACETATE; DICLOFENAC POTASSIUM /POTASSIUM [2-[(2, 6-DICHLOROPHENYL)AMINO]PHENYL]ACETATE; Cataflam; CGP-45840B; K-fenakCAS: 15307-81-0Assay: 99%M. F: C14H10Cl2KNO2M. W: 334.239BP: 412°C at760 mmHgAppearance: white or white crystalline powder, with amoist. Soluble in ethanol, soluble in water, insoluble in chloroformApplication: anew generation of potent non-steroidal anti-inflammatory drug, for phenylacetic acid derivatives. The main pharmacological effect is inhibition of cyclooxygenase, reduce the biosynthesis of prostaglandins, prostaglandin in pain, and play an important role in inflammation and feverPackage: 25kh/drumStandard: enterprise standardName: Diclofenac PotassiumSynonym: DICLOFENAC POTASSIUM; DICLOFENAC POTASSIUM SALT; 2[(2, 6-dichlorophenyl)amino]benzeneacetic acid potassium salt; POTASSIUM [2-[(2, 6-DICHLOROPHENYL)AMINO]PHENYL]ACETATE; DICLOFENAC POTASSIUM /POTASSIUM [2-[(2, 6-DICHLOROPHENYL)AMINO]PHENYL]ACETATE; Cataflam; CGP-45840B; K-fenakCAS: 15307-81-0Assay: 99%M. F: C14H10Cl2KNO2M. W: 334.239BP: 412°C at760 mmHgAppearance: white or white crystalline powder, with amoist. Soluble in ethanol, soluble in water, insoluble in chloroformApplication: anew generation of potent non-steroidal anti-inflammatory drug, for phenylacetic acid derivatives. The main pharmacological effect is inhibition of cyclooxygenase, reduce the biosynthesis of prostaglandins, prostaglandin in pain, and play an important role in inflammation and feverPackage: 25kh/drumStandard: enterprise standardOstarine,MK-2866, EnobosarmEnobosarm (Ostarine, MK-2866, GTx-024) -affects both muscle and bone, intended mainly for osteoporosis but also general treatment for andropause and reversing muscle sarcopenia in the elderly and for cachexia in cancer patients.LGD-4033pharmacological profile similar to that of enobosarm, Ostarine,MK-2866MK-677, Ibutamoren, a secretagoguea secretagogue, treatment of obesity, apromising therapy for the treatment of frailty in the elderlyAndarine (S-4)partial agonist, intended mainly for treatment of benign prostatic hypertrophyGW-501516It had been investigated as apotential treatment for obesity, diabetes, dyslipidemia and cardiovascular diseaseAICARAICAR acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown